Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 8, Number 12—December 2002

Research

Induction of Inflammation by West Nile virus Capsid through the Caspase-9 Apoptotic Pathway

Joo-Sung Yang*1, Mathura P. Ramanathan*1, Karuppiah Muthumani*, Andrew Y. Choo*, Sung-Ha Jin*, Qian-Chun Yu*, Daniel S. Hwang*, Daniel K. Choo*, Mark D. Lee*, Kesen Dang*, J. Joseph Kim†, David B. Weiner*Comments to Author , and WaixingTang
Author affiliations: *University of Pennsylvania, Philadelphia, Pennsylvania, USA; †Viral Genomix, Inc., Philadelphia, Pennsylvania, USA;

Main Article

Figure 5

Apoptosis determining domain in WNV-Cp gene. a, Schematic diagram of pcWNV-Cp-DJY, pcWNV-CpWT, and pcWNV-Cp∆3′ constructs. b, Immunoprecipitation of in vitro translated protein from pcWNV-Cp-DJY (Cp-DJY), pcWNV-CpWT (CpWT), and pcWNV-Cp-3′ (Cp∆3′) plasmids. As a negative control, pcDNA3.1 in vitro translated supernatants were analyzed. c, Colorimetric caspase-3 activity assay using pcWNV-Cp-DJY (Cp-DJY), pcWNV-CpWT (CpWT), or pcWNV-CpΔ3′ (CpΔ3’) plasmid–transfected cells. d, The cell lysates were assayed for caspase-9-like activity, and the pcDNA3.1-transfected cell lysate was used as the negative control. e, Inhibition of WNV-Cp–induced apoptosis by a dominant negative (DN) caspase-9 plasmid (DN Casp9) was assayed with equal amount of cell lysates from co-transfection of pcWNV-Cp-DJY (Cp-DJY) or pcWNV-CpWT (CpWT); an expression level of pro-caspase-9 cleavage products (35–37 kD) was compared to 3′-terminal deletion mutant, pcWNV-Cp∆3′ (Cp∆3′) and pcDNA3.1 by Western blot analysis with anti-human caspase-9 mAb.

Figure 5. Apoptosis determining domain in WNV-Cp gene. a, Schematic diagram of pcWNV-Cp-DJY, pcWNV-CpWT, and pcWNV-Cp∆3′ constructs. b, Immunoprecipitation of in vitro translated protein from pcWNV-Cp-DJY (Cp-DJY), pcWNV-CpWT (CpWT), and pcWNV-Cp-3′ (Cp∆3′) plasmids. As a negative control, pcDNA3.1 in vitro translated supernatants were analyzed. c, Colorimetric caspase-3 activity assay using pcWNV-Cp-DJY (Cp-DJY), pcWNV-CpWT (CpWT), or pcWNV-CpΔ3′ (CpΔ3’) plasmid–transfected cells. d, The cell lysates were assayed for caspase-9-like activity, and the pcDNA3.1-transfected cell lysate was used as the negative control. e, Inhibition of WNV-Cp–induced apoptosis by a dominant negative (DN) caspase-9 plasmid (DN Casp9) was assayed with equal amount of cell lysates from co-transfection of pcWNV-Cp-DJY (Cp-DJY) or pcWNV-CpWT (CpWT); an expression level of pro-caspase-9 cleavage products (35–37 kD) was compared to 3′-terminal deletion mutant, pcWNV-Cp∆3′ (Cp∆3′) and pcDNA3.1 by Western blot analysis with anti-human caspase-9 mAb.

Main Article

1 These authors contributed equally.

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO